ISOThrive obtains a patent on the composition of the material and the production method for its first “Farmaceutical™” to support animal health


HEALDSBURG, Calif., August 31, 2021 /PRNewswire/ — ISOThrive Inc., a microbiome therapeutics company, today announced that the U.S. Patent and Trademark Office has granted a composition of matter and method of production patent for its first Farmaceutical™ Maltosyl-Isomaltooligosaccharides (MIMO™), a prebiotic for use as an animal feed additive and a pet food supplement. Studies from the USDA and the University of Georgia have shown MIMO to be very effective in protecting chickens against antibiotic resistant bacteria. Salmonella while improving feed efficiency.

ISOThrive opens up a whole new market opportunity to deliver better quality, pathogen-free and leaner meats. At the same time, increased food safety is better for workers, cheaper for producers and better for the environment. Additionally, there are emerging opportunities in pet health with supplements that support better digestion with less reliance on medication.

The widespread use of antibiotics in cattle, pigs and chickens can lead to the creation of antibiotic resistant bacterial species. The same antibiotics used in animal feed are also used to treat diseases in humans. With the rise of antibiotic resistant bacteria, eliminating their use in livestock has become a necessity. Prebiotics, while providing a viable alternative to antibiotics, can be expensive to manufacture. This patent covers an economical and efficient manufacturing method (MIMO) that can be used as an animal feed additive at a significantly lower cost.

“Today’s conscious consumer wants a healthier food supply, a better environment for the people who produce the food, and has the least environmental impact,” said Jack Oswald, CEO, CTO and co-founder of ISOThrive. “This new patent allows us to unlock a new market opportunity while simultaneously having a positive impact on food safety and suitability at a cost that makes sense to producers.”

USDA researchers and University of Georgia found that MIMO added to chicken feed reduced antibiotic resistance Salmonella 99% while increasing Bifidobacteria. Feed efficiency has been increased by 9-10%.

ISOThrive Inc. is a microbiome therapeutics company focused on human and animal health.

MEDIA CONTACT: Jack Oswald [email protected] 855-552-5572



Comments are closed.